Thus, our results demonstrate that TCL1A is a client protein of HSP90A, and that HSP90A’s direct binding leads to it stabilization, thereby contributing to AKT activation in NANOGhigh tumor cells. The gene discussed is HSP90AA1; the disease is neoplasm.